- Lobbying
- Lobbying by Cure Forward
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Shelia Walcoff | 2006-07 counselor to HHS Secretary Michael Leavitt (Immediate Office of the Secretary), US Dept. of Health & Human Service 2004-2006, Assoc Commissioner for External Realtions, US FDA; 1998-99 Majority Counsel Armed Services House of Representatives |
Sheila Walcoff | 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Registration
Issue(s) they said they’d lobby about: regulation of laboratory tests, medical devices and software
21st Century Cures Initiative.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate